7.5 is the second most common therapeutic area among NAS—a positive trend.
← all excerpts
The Changing Landscape for New Drug Development: Medical Countermeasures (MCMs) as a Case Study
2
—
—
The sentences
However, the fact that neurological disease (including Parkinson’s and Alzheimer’s diseases) and cardiovascular diseases trail oncology by a considerable margin is a negative trend and brings into question the prioritization agenda of both the private and public sectors.